Anixa Biosciences ANIX
NASDAQ ANIX
$3.01 +0.23 (+8.26%)
As of: Oct 23, 2026 · 1:49 PM EDT

Anixa Biosciences (ANIX) Total Debt (2014 - 2017)

Updated

Anixa Biosciences (ANIX) reported Total Debt of $2 million for fiscal Q3 2017 (quarter ended Jul 31, 2017), down 33.3% from the prior quarter.

Analysis

Anixa Biosciences (ANIX) Total Debt (2014 - 2017) Analysis & Trends

Dating back to fiscal Q1 2014, Anixa Biosciences' Total Debt record includes 4 quarters.

  • The fiscal Q3 2017 figure ranks as the lowest quarterly Total Debt since fiscal Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,133.92 Bn 1,102.51 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 634.72 Bn 554.59 Bn 17.30 Bn 44.65 Bn
3 AbbVie 506.31 Bn 479.42 Bn 12.70 Bn 70.82 Bn
4 Merck 357.83 Bn 312.21 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 291.64 Bn 255.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 265.27 Bn 238.96 Bn 12.86 Bn 32.35 Bn
7 Amgen 238.30 Bn 193.70 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 195.34 Bn 169.53 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn 63.19 Bn
10 Anixa Biosciences 102.89 Mn 89.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2017 2.00 Mn
Apr 30, 2017 3.00 Mn
Jan 31, 2017 6.00 Mn
Jan 31, 2014 667,956.00
API Access

Anixa Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ANIX&period=max&api_key=YOUR_API_KEY